A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R. Boulware, Kathy Huppler Hullsiek, Melanie R. Nicol et al.|New England Journal of Medicine|2020Cited by 1.4k
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19Caleb P Skipper, David R. Boulware, Katelyn A Pastick et al.|Annals of Internal Medicine|2020Cited by 548
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized TrialRadha Rajasingham, Rebecca Zash, Ananta Bangdiwala et al.|Clinical Infectious Diseases|2020Cited by 128
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Adit A. Ginde et al.|The Lancet Respiratory Medicine|2022Cited by 127